361: The impact of a ban on trial of labor after cesarean (TOLAC) on primary cesarean delivery rates - 19/12/14
Doi : 10.1016/j.ajog.2014.10.407
Melissa Rosenstein 1, Steven Gregorich 2, Miriam Kuppermann 1, Yvonne Cheng 3, Aaron Caughey 4, Mary Barger 5
1 University of California, San Francisco, Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, San Francisco, CA
2 University of California, San Francisco, Department of Medicine, San Francisco, CA
3 California Pacific Medical Center, Department of Obstetrics and Gynecology, San Francisco, CA
4 Oregon Health and Science University, Department of Obstetrics and Gynecology, Portland, OR
5 University of San Diego, Hahn School of Nursing and Health Science, San Diego, CA
Le texte complet de cet article est disponible en PDF.
Plan
© 2015
Publié par Elsevier Masson SAS.
Vol 212 - N° 1S
P. S189-S190 - janvier 2015 Retour au numéro
Article précédent
- 360: Intrahepatic cholestasis of pregnancy, outcomes related to bile acid levels
- Meirav Nezer, Maayan Bas-Lando, Rivka Farkash, Nurit Algor, Arnon Samueloff, Hen Sela
- 362: Does quantitative fetal fibronectin testing add to cervical length measurement and qualitative fetal fibronectin testing; (I) Identification of low risk women with threatened preterm labor (EUFIS study)
- Merel Bruijn, Esme Kamphuis, Irene Hoesli, Begoña Martinez de Tejada, Anne Loccufier, Yves Jacquemyn, Maritta Kühnert, Hanns Helmer, Martina Porath, Martijn Oudijk, Marjolein Kok, Ben Mol, Gert-Jan Baaren
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?